Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

64.79

-0.54 (-0.83%)

Aug 7, 2026, 4:00 PM EDT - Market closed

Tarsus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-46.48	-66.42	-115.55	-135.89	-62.09	-13.83
Depreciation & Amortization	2.34	1.82	1.23	0.88	0.33	0.31
Stock-Based Compensation	51.81	41.72	27.82	19.83	13.46	8.46
Other Adjustments	-2	-4.21	-0.36	-2.61	0.23	7.44
Change in Receivables	-37.7	-38.3	-30.14	-16.62	-	-
Changes in Inventories	-0.5	-1.75	-2.05	-3.11	-	-
Changes in Accounts Payable	30.05	6.91	2.54	4.54	0.82	3.88
Changes in Accrued Expenses	61.09	47.35	40.37	16.43	2.72	1.76
Changes in Other Operating Activities	19.12	0.44	-6.89	-0.93	-4.49	-4.27
Operating Cash Flow	74.16	-12.45	-83.03	-117.49	-49.03	3.75
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-18.16	-9.86	-1.57	-1.5	-0.51	-0.59
Purchases of Intangible Assets	-	-	-5	-4	-	-
Purchases of Investments	-267.11	-394.06	-265.63	-28.66	-149.44	-
Proceeds from Sale of Investments	309.99	361.8	73	174.77	5.32	-
Investing Cash Flow	23.85	-42.12	-199.2	140.6	-144.63	-0.59

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	-	75	10	20	-
Net Long-Term Debt Issued (Repaid)	-	-	75	10	20	-
Issuance of Common Stock	9.38	143.39	115.06	120.18	74.94	0.32
Net Common Stock Issued (Repurchased)	9.38	143.39	115.06	120.18	74.94	0.32
Other Financing Activities	-	-	-35.4	-	-0.95	-0.3
Financing Cash Flow	9.38	143.39	154.66	130.18	93.99	0.02

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	107.39	88.82	-127.57	153.29	-99.67	3.18

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	56	-22.31	-84.59	-119	-49.54	3.16
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	9.24%	-4.94%	-46.24%	-682.04%	-191.88%	5.54%
Free Cash Flow Per Share	1.30	-0.53	-2.25	-4.05	-2.01	0.15
Levered Free Cash Flow	47.46	-21.53	-6.91	-109.59	-43.22	-12.73
Unlevered Free Cash Flow	45.4	-23.81	-86.93	-126.86	-63.85	-11

SEC Filings: 10-K · 10-Q